‘Lehua Gray, a 32-year-old product manager in Austin, wants to risk her life for a coronavirus vaccine. A cloud of potentially deadly microbes would be spritzed up her nose — if she’s allowed to a participate in what’s called a human challenge trial.
‘It’s built on a deceptively simple premise: Researchers inject healthy volunteers with an experimental vaccine and then expose them to a pathogen. If the vaccine prevents volunteers from getting sick, the study can accelerate development of a promising formula.’
Read here (Washington Post, June 15, 2020)
